Study identifies possible COVID-19 drugs -- including several that are FDA-approved

(University of Pennsylvania School of Medicine) Of the nine drugs found to reduce SARS-CoV-2 replication in respiratory cells, three already have FDA approval: the transplant-rejection drug cyclosporine, the cancer drug dacomitinib, and the antibiotic salinomycin.